OncoGenex to commence Phase 2 Rainier trial assessing pancreatic cancer drug
Around 130 patients will be randomized with either OGX-427 or placebo in combination with ABRAXANE and gemcitabine therapy in the investigator-sponsored, placebo-controlled trial. The primary endpoint is overall
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.